Investigating how DNA damage causes inflammation in the brain
DNA damage-induced inflammation and its brain-specific consequences
This study is looking at how damage to DNA in brain cells can lead to inflammation, which might play a role in diseases like Alzheimer's and Parkinson's, and it aims to understand how different brain cells react to this stress.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10694526 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of DNA damage in triggering inflammation within the brain, particularly in the context of neurodegenerative diseases like Alzheimer's and Parkinson's. It examines how the innate immune system responds to the presence of cytoplasmic DNA, which can be released during cellular stress. By analyzing different cell types in the brain, the study aims to identify their contributions to chronic inflammation associated with these diseases. The researchers will utilize various stressors to simulate conditions relevant to Alzheimer's and Parkinson's, allowing for a comprehensive understanding of the inflammatory processes involved.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's or Parkinson's disease who are experiencing symptoms related to chronic inflammation.
Not a fit: Patients with neurodegenerative diseases not related to inflammation or those in very early stages of disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing inflammation in neurodegenerative diseases, potentially slowing disease progression.
How similar studies have performed: Previous research has shown that targeting inflammatory processes in neurodegenerative diseases can yield promising results, indicating that this approach may also be effective.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Herrup, Karl — University of Pittsburgh at Pittsburgh
- Study coordinator: Herrup, Karl
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.